- Home
- RFIL vs ARMP Comparison
RFIL vs ARMP Comparison
Compare RFIL & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- ARMP
- Stock Information
- Founded
- RFIL 1979
- ARMP N/A
- Country
- RFIL United States
- ARMP United States
- Employees
- RFIL N/A
- ARMP N/A
- Industry
- RFIL Electrical Products
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RFIL Technology
- ARMP Health Care
- Exchange
- RFIL Nasdaq
- ARMP Nasdaq
- Market Cap
- RFIL 44.7M
- ARMP 52.1M
- IPO Year
- RFIL N/A
- ARMP N/A
- Fundamental
- Price
- RFIL $5.65
- ARMP $1.93
- Analyst Decision
- RFIL Strong Buy
- ARMP Strong Buy
- Analyst Count
- RFIL 1
- ARMP 1
- Target Price
- RFIL $4.50
- ARMP $9.00
- AVG Volume (30 Days)
- RFIL 98.7K
- ARMP 23.1K
- Earning Date
- RFIL 06-16-2025
- ARMP 08-12-2025
- Dividend Yield
- RFIL N/A
- ARMP N/A
- EPS Growth
- RFIL N/A
- ARMP N/A
- EPS
- RFIL N/A
- ARMP N/A
- Revenue
- RFIL $73,399,000.00
- ARMP $4,699,000.00
- Revenue This Year
- RFIL $16.16
- ARMP $8.43
- Revenue Next Year
- RFIL $9.55
- ARMP N/A
- P/E Ratio
- RFIL N/A
- ARMP N/A
- Revenue Growth
- RFIL 20.14
- ARMP 14.24
- 52 Week Low
- RFIL $3.27
- ARMP $0.90
- 52 Week High
- RFIL $6.54
- ARMP $3.42
- Technical
- Relative Strength Index (RSI)
- RFIL 76.51
- ARMP 51.96
- Support Level
- RFIL $4.08
- ARMP $1.74
- Resistance Level
- RFIL $5.84
- ARMP $2.00
- Average True Range (ATR)
- RFIL 0.34
- ARMP 0.15
- MACD
- RFIL 0.14
- ARMP -0.02
- Stochastic Oscillator
- RFIL 89.78
- ARMP 44.74
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.